🇺🇸 FDA
Patent

US 9617526

Mutated organophosphorus acid anhydrolases and their uses thereof

granted A61KA61K38/465

Quick answer

US patent 9617526 (Mutated organophosphorus acid anhydrolases and their uses thereof) held by The United States of America as represented by the Secretary of the Army expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/465